基于CXC化学基因的血管重编程:调节瘤血管结构以提高治疗反应
Hongdan Chen1,2,3, Yinde Huang1, Juntong Wu1,2
1Department of Breast and Thyroid Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 21, 2026
概括
这项研究引入了一种新的以化学为中心的癌症治疗方法,超越了VEGF. 它提出了新的分子工具来评估瘤血管结构,并指导治疗以获得更好的血管正常化和免疫调节.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 异常的瘤血管系统有助于癌症的进展,免疫逃避和治疗耐药性.
- 目前的血管正常化策略,主要以VEGF为重点,缺乏对血管功能的分子洞察力.
- 需要先进的方法来评估治疗窗口并改善血管-免疫相互作用.
研究的目的:
- 为理解和操纵瘤血管功能引入一个以化基因为中心的框架.
- 为实时血管评估和治疗分层提出新的分子工具.
- 概述针对性CXC化学激素策略,用于增强癌症治疗.
主要方法:
- 开发了一个以化基因为中心的视角,专注于CXC化基因网络.
- 分析的机械维度:双向性,时间动态和组织特异性.
- 提出了功能性血管正常化得分 (FVNS) 和化学激素引导的血管正常化窗口 (VNW).
主要成果:
- 通过相互连接的机制,CXC化学基因网络动态调节血管功能.
- FVNS和VNW提供分子工具,用于实时血管评估和治疗规划.
- 针对CXC的策略,如CXCR2/CXCR4阻断和CXCL9/10/11增强,显示出治疗潜力.
结论:
- 一个以化基因为重点的范式提供了一种功能性和可实施的方法,将血管正常化和免疫调节整合到癌症治疗中.
- 这一框架通过扩展和完善VNW,使个性化治疗策略成为可能.
- 提出的工具和策略可以通过向瘤血管和免疫反应来提高癌症治疗的疗效.
更多相关视频
相关概念视频
01:30Inflammatory Response I: Vascular and Cellular
16.2K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.2K
03:24Seedless Vascular Plants
66.7K
Seedless Vascular Plants Were the First Tall Plants on Earth
66.7K
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
01:14Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
01:24Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
01:27ATP Driven Pumps I: An Overview
9.7K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.7K